Malcolm Lloyd-Smith, Chief Integration Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,332 shares at $110.02 ($367K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Seasonal sale ($367k) by Chief Integration Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.02 | 1,666 | $183K | 50.0% |
| 2 | $110.02 | 1,666 | $183K | 50.0% |
| Total | $110.02 avg | 3,332 | $367K | 100% |
| Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |
| NBIX | SELL | 2021-02-12 | $204K | — | Filing → |